Bao et al. [32] found no relationship between FOXD2-AS1 and clinicopathological characteristics, but observed that elevated FOXD2-AS1 expression was associated with a poor OS and DFS in ESCC. The gene discussed is FOXD2; the disease is esophageal squamous cell carcinoma.